|
Susie Lee
|
house |
CrowdStrike Holdings, Inc. - Class A (CRWD) |
CRWD |
STOCK |
Sale
|
March 23, 2021 |
$$15,001 - $50,000 |
May 5, 2021 |
|
Andrew Saul
|
executive |
salesforce.com, inc. (CRM) |
CRM |
STOCK |
Purchase
|
March 8, 2021 |
$$1,001 - $15,000 |
April 20, 2021 |
|
Virginia Foxx
|
house |
Hartford Core Bond ETF (HCRB) |
HCRB |
ETF |
Sale
|
March 8, 2021 |
$$15,001 - $50,000 |
April 5, 2022 |
|
Josh Gottheimer
|
house |
Cree, Inc. (CREE) |
CREE |
STOCK |
Purchase
|
Feb. 23, 2021 |
$$1,001 - $15,000 |
March 10, 2021 |
|
John A. Yarmuth
|
house |
Cronos group Inc. - Common Share (CRON) |
CRON |
STOCK |
Purchase
|
Feb. 12, 2021 |
$$1,001 - $15,000 |
Feb. 19, 2021 |
|
Josh Gottheimer
|
house |
Salesforce.com Inc (CRM) |
CRM |
STOCK |
Sale
|
Feb. 12, 2021 |
$$1,001 - $15,000 |
March 10, 2021 |
|
Andrew Saul
|
executive |
salesforce.com, inc. (CRM) |
CRM |
STOCK |
Purchase
|
Feb. 8, 2021 |
$$50,001 - $100,000 |
March 24, 2021 |
|
Janet L Yellen
|
executive |
NCR Corp. (NCR) |
NCR |
STOCK |
Sale
|
Feb. 8, 2021 |
$$1,001 - $15,000 |
March 11, 2021 |
|
Rohit Khanna
|
house |
SALESFORCE COM INC COM |
CRM |
STOCK |
Purchase
|
Feb. 7, 2021 |
$28,000 |
Nov. 9, 2021 |
|
Rohit Khanna
|
house |
CROCS INC |
CROX |
STOCK |
Sale
|
Feb. 5, 2021 |
$21,000/23,000 |
March 8, 2022 |
|
Rohit Khanna
|
house |
SALESFORCE COM INC |
CRM |
STOCK |
Sale
|
Feb. 5, 2021 |
$21,000/23,000 |
March 8, 2022 |
|
Rohit Khanna
|
house |
SALESFORCE COM INC |
CRM |
STOCK |
Sale
|
Feb. 5, 2021 |
$21,000/23,000 |
March 8, 2022 |
|
Rohit Khanna
|
house |
CROCS INC |
CROX |
STOCK |
Sale
|
Feb. 5, 2021 |
$21,000/23,000 |
March 8, 2022 |
|
Susie Lee
|
house |
CrowdStrike Holdings, Inc. - Class A (CRWD) |
CRWD |
STOCK |
Purchase
|
Jan. 28, 2021 |
$$1,001 - $15,000 |
Feb. 10, 2021 |
|
Tom Malinowski
|
house |
Pacira BioSciences, Inc. (PCRX) |
PCRX |
STOCK |
Short Sale
|
Jan. 25, 2021 |
$$1,001 - $15,000 |
Aug. 26, 2021 |
|
Marie Newman
|
house |
Salesforce.com Inc (CRM) |
CRM |
STOCK |
Sale
|
Jan. 22, 2021 |
$$15,001 - $50,000 |
Feb. 13, 2021 |
|
Marjorie Taylor Greene
|
house |
CRISPR Therapeutics AG - Common Shares (CRSP) |
CRSP |
STOCK |
Purchase
|
Jan. 21, 2021 |
$$1,001 - $15,000 |
Feb. 19, 2021 |
|
Tom Malinowski
|
house |
Pacira BioSciences, Inc. (PCRX) |
PCRX |
STOCK |
Purchase
|
Jan. 15, 2021 |
$$1,001 - $15,000 |
March 5, 2021 |
|
Andrew Saul
|
executive |
salesforce.com, inc. (CRM) |
CRM |
STOCK |
Purchase
|
Jan. 13, 2021 |
$$15,001 - $50,000 |
Feb. 24, 2021 |
|
Josh Gottheimer
|
house |
Salesforce.com Inc (CRM) |
CRM |
STOCK |
Purchase
|
Jan. 11, 2021 |
$$1,001 - $15,000 |
Feb. 9, 2021 |
|
James M Inhofe
|
senate |
CRISPR Therapeutics AG |
CRSP |
STOCK |
Sale (Partial)
|
Jan. 5, 2021 |
$$1,001 - $15,000 |
Jan. 15, 2021 |
|
James M Inhofe
|
senate |
CRISPR Therapeutics AG |
CRSP |
STOCK |
Sale (Partial)
|
Dec. 22, 2020 |
$$50,001 - $100,000 |
Dec. 23, 2020 |
|
Dean Phillips
|
house |
Salesforce.com Inc (CRM) |
CRM |
STOCK |
Sale (partial)
|
Dec. 18, 2020 |
$$15,001 - $50,000 |
Jan. 9, 2021 |
|
Josh Gottheimer
|
house |
Salesforce.com Inc (CRM) |
CRM |
STOCK |
Sale
|
Dec. 11, 2020 |
$$1,001 - $15,000 |
Jan. 7, 2021 |
|
Mark W Menezes
|
executive |
salesforce.com, inc. (CRM) |
CRM |
STOCK |
Purchase
|
Dec. 9, 2020 |
$$1,001 - $15,000 |
Feb. 23, 2021 |